These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
4. Ethics and AIDS drugs. Dowell W Time; 1999 Jul; 154(2):49. PubMed ID: 10538646 [No Abstract] [Full Text] [Related]
5. No money, no meds. Mabry M Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648 [No Abstract] [Full Text] [Related]
6. World Trade Organization still threatens supply of affordable AIDS drugs. Hagmann M Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300 [No Abstract] [Full Text] [Related]
7. Innovation and the WHO's essential medicines list: giving credit where credit is due. Wertheimer AI; Santella TM Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562 [No Abstract] [Full Text] [Related]
8. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
9. Africa could learn from India's burgeoning pharma sector. Selvaraj S BMJ; 2013 Aug; 347():f4235. PubMed ID: 23913693 [No Abstract] [Full Text] [Related]
10. The GO License: only part of the solution. Batson A; Milstien JB Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489 [TBL] [Abstract][Full Text] [Related]
11. Access to essential drugs, human rights and global justice. Shalev C Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024 [No Abstract] [Full Text] [Related]
12. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world. Tucker T; Yeats J S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766 [No Abstract] [Full Text] [Related]
13. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care. Work DR; Domino ME N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614 [No Abstract] [Full Text] [Related]
14. [Access for all to quality drugs]. Videau JY Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178 [TBL] [Abstract][Full Text] [Related]
15. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries. Spectar JM Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914 [No Abstract] [Full Text] [Related]
17. Generic drugs battle moves from South Africa to Kenya. Siringi S Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665 [No Abstract] [Full Text] [Related]
18. Cut-rate AIDS. Golden F Time; 2001 Mar; 157(11):68. PubMed ID: 11276822 [No Abstract] [Full Text] [Related]
19. Reprivatizing pharmaceutical supplies in Africa. Turshen M J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153 [TBL] [Abstract][Full Text] [Related]
20. Cheap HIV drugs for developing countries. Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820 [No Abstract] [Full Text] [Related] [Next] [New Search]